Artivion (AORT) Other financing activities (2010 - 2026)
Artivion (AORT) posted Other financing activities of -$210000.0 for Q1 2026, down 21.39% on a QoQ basis from -$173000.0 in Q4 2025, and down 17.98% year-over-year from -$256027.4 in Q1 2025.
Artivion (AORT) Other financing activities (2010 - 2026) Analysis & Trends
Artivion's Other financing activities history runs 17 years deep, the most recent figure standing at -$210000.0 for Q1 2026.
- Quarterly Other financing activities fell 17.98% year-over-year to -$210000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$731000.0 (down 10.42% YoY) and the FY2025 annual result came in at -$699000.0, down 12.2% from the prior year.
- Other financing activities was -$210000.0 for Q1 2026 at Artivion, down from -$173000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $408000.0 in Q4 2023 and bottomed at -$720000.0 in Q1 2023.
- A 5-year average of -$148705.9 and a median of -$148000.0 in 2024 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 356.6% in 2023, while the deepest fall reached 458.14% in 2023.
- Artivion's Other financing activities stood at -$159000.0 in 2022, then surged by 356.6% to $408000.0 in 2023, then slumped by 149.75% to -$203000.0 in 2024, then advanced by 14.78% to -$173000.0 in 2025, then fell by 21.39% to -$210000.0 in 2026.
- Business Quant data shows AORT's Other financing activities at -$210000.0 in Q1 2026, -$173000.0 in Q4 2025, and -$173000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Artivion | 1.25 Bn | 1.19 Bn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -210,000.00 |
| Mar 31, 2026 | -210,000.00 |
| Dec 31, 2025 | -173,000.00 |
| Dec 31, 2025 | -173,000.00 |
| Sep 30, 2025 | -173,000.00 |
| Sep 30, 2025 | -173,000.00 |
| Jun 30, 2025 | -175,000.00 |
| Jun 30, 2025 | -175,000.00 |
| Mar 31, 2025 | -178,000.00 |
| Mar 31, 2025 | -178,000.00 |
| Dec 31, 2024 | -203,000.00 |
| Dec 31, 2024 | -203,000.00 |
| Sep 30, 2024 | -148,000.00 |
| Sep 30, 2024 | -148,000.00 |
| Jun 30, 2024 | -133,000.00 |
| Jun 30, 2024 | -133,000.00 |
| Mar 31, 2024 | -139,000.00 |
| Mar 31, 2024 | -139,000.00 |
| Dec 31, 2023 | 408,000.00 |
| Dec 31, 2023 | 408,000.00 |